BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 12082636)

  • 21. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT; You L; Uematsu K; Yeh CC; McCormick F; Jablons DM
    Cancer Res; 2001 Aug; 61(16):5959-63. PubMed ID: 11507034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity.
    Normand G; Hemmati PG; Verdoodt B; von Haefen C; Wendt J; Güner D; May E; Dörken B; Daniel PT
    J Biol Chem; 2005 Feb; 280(8):7118-30. PubMed ID: 15582998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human tumor suppressor ARF impedes S-phase progression independent of p53.
    Yarbrough WG; Bessho M; Zanation A; Bisi JE; Xiong Y
    Cancer Res; 2002 Feb; 62(4):1171-7. PubMed ID: 11861400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
    Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
    Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
    Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
    J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
    Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
    Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
    Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus.
    Robertson KD; Jones PA
    Oncogene; 1999 Jul; 18(26):3810-20. PubMed ID: 10445844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.
    Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.